Lluna Gallego Segrelles is the Co-founder and CEO of Vector Bioscience Cambridge. In this role, she operates at the intersection of drug delivery, oncology, and translational science, ensuring the company's technology progresses to market with purpose. She is responsible for driving Vector's commercial and investment strategy, engaging with pharma, biotech, investors, and academic partners to foster growth and impact.